Tag: Vaccines
Recombinant Zoster Vaccine Cost-Effective in Simulation
Incremental cost-effectiveness ratio varied from $10,000 to $47,000 per QALY for RZV versus no vaccine
High Rates of MenB Vaccination Advised in University Outbreaks
Estimated first-dose vaccination coverage varied from 14 to 98 percent in 10 university outbreaks
CDC: Severity of Influenza Season Low Through Feb. 2, 2019
Vaccine effectiveness 47 percent against all flu virus infection associated with acute respiratory illness
Vaccine-Preventable Infections Common After Peds Transplant
These infections in organ transplant recipients associated with significant morbidity, mortality, costs
Measles Outbreak Triggers Sharp Rise in Demand for Vaccine
More than 50 confirmed cases of measles, 11 suspected cases reported in Clark County, Washington, this year
AAP Releases 2019 Childhood Immunization Schedules
Influenza row modified to reflect current recommendations for live attenuated flu vaccine
CDC Examines Safety of Recombinant Zoster Vaccine
Total of 4,381 reports of adverse events during first eight months of use; 3 percent were serious
Updated ACIP Immunization Schedule Released for Adults
Changes recommended to influenza vaccine, hepatitis A and B vaccines
HPV Educational Video May Increase Vaccination Rates
Adolescents whose parents watched the video were three times more likely to be vaccinated
Many Teens Not Up to Date on HPV Vaccination
Only 15.7 and 34.8 percent of teens completed HPV vaccination before turning 13 and 15
